Skip to main content
Home
  • Affected by Cancer
  • Healthy Living
  • Clinical Best Practice
  • Research & Data
  • Publications & Resources
  • About Us
  • Home
  • Affected by Cancer
    • What is cancer
    • Cancer A-Z
    • Cancer statistics
    • Interactive body map
    • Check your cancer risk online
    • Treatment
    • Living with cancer
    • Life after cancer
    • For Aboriginal and Torres Strait Islander people
    • Cancer support organisations
    • Australian cancer trials
    • Jeannie Ferris Award
    • Information about cancer and COVID-19
    • Culturally and Linguistically Diverse (CALD) Resources
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children's Cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma of the skin
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary
    • Uterine sarcoma
    • Vaginal cancer
    • Vulval cancer
  • Healthy Living
    • Lifestyle & risk reduction
    • Screening
  • Clinical Best Practice
    • Cancer types
    • Psychosocial care
    • Multidisciplinary care
    • Cancer learning
    • Australian cancer trials
    • Consumer engagement
    • Shared follow-up care
  • Research & Data
    • Research
    • Grants and funding
    • Support for clinical trials
    • Cancer data
  • Publications & Resources
    • Cancer Australia publications
    • Position statements
    • Clinical Practice Guidelines
    • Cancer Australia websites
    • Cancer risk online tools
    • Other tools and resources
    • Podcasts
    • Subscribe to our eNewsletter
    • Glossary
  • About Us
    • Strategic Plan 2014-2019
    • Organisational structure
    • Accountability and reporting
    • Position Statements
    • Who we work with
    • Lung Cancer Screening enquiry
    • National Pancreatic Cancer Roadmap
    • News
    • Media
    • Campaigns & events
    • Information publication scheme
    • Reconciliation action plan
    • Employment opportunities
    • Contact us

Breast cancer

breast-mm affected-cancer/cancer-types/breast-cancer/what-breast-cancer
    • Home
    • Types
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Statistics
    • Risk factors
    • Symptoms
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget’s disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Awareness
      • iPrevent
    • Diagnosis
      • Tests
        • Triple test
      • Stages of breast cancer
      • Receiving a diagnosis
      • Diagnosis of early breast cancer
        • What the pathology report means
      • Diagnosis of ductal carcinoma in situ
        • What the DCIS pathology report means
      • Diagnosis when breast cancer spreads
      • Questions to ask
    • Treatment
      • Treatment team
        • Members of the team
        • Talking with health professionals
        • Questions to ask
      • Deciding about treatment
        • Travelling
        • Pregnancy
        • Tips for making decisions
        • Questions to ask
        • MammaPrint ® (70 gene signature) test
      • Surgery
        • Breast-conserving surgery
        • Mastectomy
        • Surgery to the armpit (axilla)
        • Surgery for metastatic breast cancer
        • Breast reconstruction
        • Choosing a surgeon
        • Questions to ask
        • Care after surgery
      • Radiotherapy
        • Early breast cancer
        • Metastatic breast cancer
        • Questions to ask
        • Skin care
        • Travelling
      • Chemotherapy
        • How does chemotherapy work?
        • Type of chemotherapy
        • What does chemotherapy involve?
        • Side effects
        • Questions to ask
      • Hormonal therapies
        • Hormone receptors
        • Types of hormonal therapy
        • Side effects
        • Menopause and oestrogen production
        • Deciding about hormonal therapies
        • Questions to ask
      • Targeted therapies
        • HER2 receptors
        • Types of targeted therapy
        • Questions to ask
      • Complementary & alternative therapies
        • Complementary therapies
        • Questions to ask
        • Where to find more information
      • Metastatic breast cancer palliative care
        • What is palliative care?
        • Accessing palliative care
        • Questions to ask
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
      • Follow-up
        • Physical examinations
        • Breast imaging tests
        • Questions to ask
      • Advanced disease
        • When treatment stops
        • Facing the possibility of dying
        • Putting your affairs in order
        • Questions to ask
      • Recurrent and secondary cancer
        • What makes spread more likely
    • Living with
      • Practical aspects of diagnosis
        • Costs of treatment and prostheses
        • Travel schemes
        • Questions to ask
        • Choosing a cancer treatment
      • Physical changes
        • Body image
        • Menopause
        • Fertility
        • Lymphoedema
      • Emotional changes
        • How you might feel
        • Effects on partners
        • Effects on children
        • Effects on family and friends
      • Physical changes – metastatic
        • Pain
        • Symptoms and treatment side effects
      • Emotional changes – metastatic
        • Common feelings
      • Practical aspects - metastatic
        • Work
        • Financial support
        • How to access support at home
        • How to access support outside home
        • Questions to ask
    • Life after
      • Health
        • Fatigue
        • Poor sleep
        • Lymphoedema
        • Menopause
        • Pain
        • Diet
        • Exercise
      • Feelings
        • Finding a new ‘normal’
        • Fear of recurrence
        • Feelings of loss
        • Isolation
        • Anxiety and depression
        • Not sure how you feel?
      • Relationships
        • Partners
        • Children
        • Friends
        • Colleagues
      • Practical issues
        • Returning to work
        • Questions to ask your health fund
    • Support
    • Clinical trials
      • What happens in a clinical trial?
      • What are the phases of a clinical trial?
      • Advantages and disadvantages
      • Questions to ask about clinical trials
      • When to find more information
    • Health professionals
      • Menopausal symptoms
      • Screening
      • Breast cancer diagnosis
      • Early breast cancer
      • Metastatic breast cancer
      • Ductal carcinoma
      • Lobular carcinoma
      • GP guides and resources
      • Follow-up care
      • Breast cancer Qstream
    • Home
    • Types
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Statistics
    • Risk factors
    • Symptoms
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget’s disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
    • Awareness
      • iPrevent
    • Diagnosis
      • Tests
        • Triple test
      • Stages of breast cancer
      • Receiving a diagnosis
      • Diagnosis of early breast cancer
        • What the pathology report means
      • Diagnosis of ductal carcinoma in situ
        • What the DCIS pathology report means
      • Diagnosis when breast cancer spreads
      • Questions to ask
    • Treatment
      • Treatment team
        • Members of the team
        • Talking with health professionals
        • Questions to ask
      • Deciding about treatment
        • Travelling
        • Pregnancy
        • Tips for making decisions
        • Questions to ask
        • MammaPrint ® (70 gene signature) test
      • Surgery
        • Breast-conserving surgery
        • Mastectomy
        • Surgery to the armpit (axilla)
        • Surgery for metastatic breast cancer
        • Breast reconstruction
        • Choosing a surgeon
        • Questions to ask
        • Care after surgery
      • Radiotherapy
        • Early breast cancer
        • Metastatic breast cancer
        • Questions to ask
        • Skin care
        • Travelling
      • Chemotherapy
        • How does chemotherapy work?
        • Type of chemotherapy
        • What does chemotherapy involve?
        • Side effects
        • Questions to ask
      • Hormonal therapies
        • Hormone receptors
        • Types of hormonal therapy
        • Side effects
        • Menopause and oestrogen production
        • Deciding about hormonal therapies
        • Questions to ask
      • Targeted therapies
        • HER2 receptors
        • Types of targeted therapy
        • Questions to ask
      • Complementary & alternative therapies
        • Complementary therapies
        • Questions to ask
        • Where to find more information
      • Metastatic breast cancer palliative care
        • What is palliative care?
        • Accessing palliative care
        • Questions to ask
      • Ductal carcinoma in situ
      • Lobular carcinoma in situ
      • Early breast cancer
      • Paget's disease of the nipple
      • Inflammatory breast cancer
      • Locally advanced breast cancer
      • Metastatic breast cancer
      • Follow-up
        • Physical examinations
        • Breast imaging tests
        • Questions to ask
      • Advanced disease
        • When treatment stops
        • Facing the possibility of dying
        • Putting your affairs in order
        • Questions to ask
      • Recurrent and secondary cancer
        • What makes spread more likely
    • Living with
      • Practical aspects of diagnosis
        • Costs of treatment and prostheses
        • Travel schemes
        • Questions to ask
        • Choosing a cancer treatment
      • Physical changes
        • Body image
        • Menopause
        • Fertility
        • Lymphoedema
      • Emotional changes
        • How you might feel
        • Effects on partners
        • Effects on children
        • Effects on family and friends
      • Physical changes – metastatic
        • Pain
        • Symptoms and treatment side effects
      • Emotional changes – metastatic
        • Common feelings
      • Practical aspects - metastatic
        • Work
        • Financial support
        • How to access support at home
        • How to access support outside home
        • Questions to ask
    • Life after
      • Health
        • Fatigue
        • Poor sleep
        • Lymphoedema
        • Menopause
        • Pain
        • Diet
        • Exercise
      • Feelings
        • Finding a new ‘normal’
        • Fear of recurrence
        • Feelings of loss
        • Isolation
        • Anxiety and depression
        • Not sure how you feel?
      • Relationships
        • Partners
        • Children
        • Friends
        • Colleagues
      • Practical issues
        • Returning to work
        • Questions to ask your health fund
    • Support
    • Clinical trials
      • What happens in a clinical trial?
      • What are the phases of a clinical trial?
      • Advantages and disadvantages
      • Questions to ask about clinical trials
      • When to find more information
    • Health professionals
      • Menopausal symptoms
      • Screening
      • Breast cancer diagnosis
      • Early breast cancer
      • Metastatic breast cancer
      • Ductal carcinoma
      • Lobular carcinoma
      • GP guides and resources
      • Follow-up care
      • Breast cancer Qstream
  1. Home
  2. Statistics

Breast cancer in Australia statistics

  • Printer-friendly version
  • A|A

The following material has been sourced from the Australian Institute of Health and Welfare

Breast cancer incorporates ICD-10 cancer code C50 (Malignant neoplasm of breast).


Estimated number of new cases of breast cancer diagnosed in 2020

19,974 = male icon 167 males + female icon 19,807 females


Estimated % of all new cancer cases diagnosed in 2020

14%


Estimated number of deaths from breast cancer in 2020

3,031 = male icon 33 males + female icon 2,997 females


Estimated % of all deaths from cancer in 2020

6.3%


Chance of surviving at least 5 years (2012–2016)

91%


People living with breast cancer at the end of 2014 (diagnosed in the 5 year period 2010 to 2014)

74,482


New cases

In 2016, breast cancer was the second most commonly diagnosed cancer in Australia and the most commonly diagnosed cancer in females. It is estimated that it will become the most commonly diagnosed cancer in 2020 among persons overall and among females.

In 2016, there were 17,492 new cases of breast cancer diagnosed in Australia (138 males and 17,354 females). In 2020, it is estimated that 19,974 new cases of breast cancer will be diagnosed in Australia (167 males and 19,807 females).

Figure 1. Estimated most common cancers diagnosed, 2020

Notes

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about incidence rates for the most common cancers diagnosed can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence)

In 2016, the age-standardised incidence rate was 65 cases per 100,000 persons (1.0 for males and 126 for females). In 2020, it is estimated that the age-standardised incidence rate will increase to 69 cases per 100,000 persons (1.1 for males and 133 for females). The incidence rate for breast cancer is expected to increase with age for both males and females, peaking at age group 70-74 for females.

Figure 2. Age-standardised incidence rates for breast cancer, 1982 to 2016, by sex

Notes

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about incidence rates for breast cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence)

The number of new cases of breast cancer diagnosed increased from 5,374 (61 males and 5,313 females) in 1982 to 17,492 in 2016. Over the same period, the age-standardised incidence rate increased from 44 cases per 100,000 persons (1.2 for males and 81 for females) in 1982 to 65 cases per 100,000 in 2016.

Deaths

In 2018, breast cancer was the fifth leading cause of cancer death in Australia and also the second most common cause of death from cancer among females.

In 2020, it is estimated that it will remain the fifth most common cause of death from cancer and the second most common cause of death from cancer among females. In 2018, there were 3,034 deaths from breast cancer in Australia (35 males and 2,999 females). In 2020, it is estimated that there will be 3,031 deaths (33 males and 2,997 females).

Figure 3. Estimated most common causes of cancer death, 2020

Notes

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about mortality rates for the most common causes of cancer death can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality)

In 2018, the age-standardised mortality rate was 10 deaths per 100,000 persons (0.3 for males and 19 for females). In 2020, it is estimated that the age-standardised mortality rate will be 9.7 deaths per 100,000 persons (0.2 for males and 18 for females). The mortality rate for breast cancer is expected to increase with age for females, and be higher among males aged 70 years or over.

Figure 4. Age-standardised mortality rates for breast cancer, 1982 to 2018, by sex

Notes

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about mortality rates for breast cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality)

The number of deaths from breast cancer increased from 2,004 (17 males and 1,987 females) in 1982 to 3,034 in 2018. Over the same period, the age-standardised mortality rate decreased from 17 deaths per 100,000 persons (0.4 for males and 30 for females) in 1982 to 10 deaths per 100,000 in 2018.

Survival

In 2012–2016, individuals diagnosed with breast cancer had a 91% chance (85% for males and 91% for females) of surviving for five years compared to their counterparts in the general Australian population. Between 1987–1991 and 2012–2016, five-year relative survival for breast cancer improved from 75% to 91%.

Figure 5. 5-year relative survival for breast cancer, 1987–1991 to 2012–2016, by sex

Notes

  • Data sourced from AIHW Cancer Data in Australia 2020 web report and supplementary data tables
  • More information about 5-year relative survival rates for female breast cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Relative survival rate’ section (https://ncci.canceraustralia.gov.au/outcomes/relative-survival-rate/5-year-relative-survival)

Prevalence

At the end of 2015, there were 16,746 people living who had been diagnosed with breast cancer that year, 74,482 people living who had been diagnosed with breast cancer in the previous 5 years (from 2011 to 2015) and 223,303 people living who had been diagnosed with breast cancer in the previous 34 years (from 1982 to 2015).

For more information, see Breast cancer on the NCCI website

The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes.  The NCCI website allows users to see visual representations of data on each indicator through interactive charts.

  • Last Updated
  • Relevant Links
updated: 20 October 2020 - 3:32pm
Australian Cancer Trials

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Affected by Cancer
  • Healthy Living
  • Clinical Best Practice
  • Research & Data
  • Publications & Resources
  • About Us

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2021 - Cancer Australia